AstraZeneca Vows to Shield Vulnerable From Infections at IDWeek 2023

Real-world data from INFORM study demonstrate increased risk of severe COVID-19
outcomes among all individuals with immunocompromising conditions
and highlight need for additional protection

FluMist Quadrivalent data support the potential for a self-administered influenza vaccine to expand
access to an important tool for prevention

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.